Mr. Speaker, in contrast to the other side, our government has been aggressively pursuing new bio-manufacturing capacity. We have taken serious action since well before the pandemic.
In our first mandate, we restored the ability for ISED to invest in life sciences, which had been pulled back by the previous government. We have accelerated our investments significantly since the pandemic, with major investments in our manufacturing capacity, Medicago, the National Research Council in Montreal. We are on our way to building a beautiful portfolio of vaccines. It will be delivered when Health Canada says they are ready.